...
首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts
【24h】

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts

机译:通过将分子和临床病理因子集成在早期子宫内膜癌综合分析中的分子和临床病理因子来改善风险评估

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Recommendations for adjuvant treatment for women with early-stage endometrial carcinoma are based on clinicopathologic features. Comprehensive genomic characterization defined four subgroups: p53-mutant, microsatellite instability (MSI), POLE-mutant, and no specific molecular profile (NSMP). We aimed to confirm the prognostic capacity of these subgroups in large randomized trial populations, investigate potential other prognostic classifiers, and integrate these into an integrated molecular risk assessment guiding adjuvant therapy.
机译:目的:提出早期子宫内膜癌患者的辅助治疗的建议是基于临床病理学特征。 综合基因组表征定义了四个亚组:P53-突变体,微卫星不稳定性(MSI),极突变体,没有特定的分子曲线(NSMP)。 我们的旨在确认这些亚组在大型随机试验群体中的预后能力,调查潜在的其他预后分类器,并将这些含量整合到综合分子风险评估引导佐剂治疗中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号